Using pharmacokinetic and pharmacodynamic principles to evaluate individualisation of antibiotic dosing : emphasis on cefuroxime.
作者： Anders Viberg
DOI:
关键词:
摘要: Cefuroxime is a renally eliminated antibiotic used against variety of different bacterial infections. The pharmacokinetics (PK) for cefuroxime was studied in 97 hospitalized patients using popula ...
参考文章(75)
Grubb A, Nilsson-Ehle P, New markers for the determination of GFR: iohexol clearance and cystatin C serum concentration. Kidney International. ,vol. 47, ,(1994)
Frieder K. Kees, K. G. Naber, H. Grobecker, U. Lukassek, Comparative investigations on the bioavailability of cefuroxime axetil. Drug Research. ,vol. 41, pp. 843- 846 ,(1991)
Lewis B. Sheiner, Stuart Beal, Barr Rosenberg, Vinay V. Marathe, Forecasting individual pharmacokinetics Clinical Pharmacology & Therapeutics. ,vol. 26, pp. 294- 305 ,(1979) , 10.1002/CPT1979263294
Kyungsoo Park, Davide Verotta, Suneel K. Gupta, Lewis B. Sheiner, Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile. Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 26, pp. 471- 492 ,(1998) , 10.1023/A:1021068202606
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
Katie W. Schaul, Lawrence A. Potempa, Marjan Motie, Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice. Drug Metabolism and Disposition. ,vol. 26, pp. 977- 981 ,(1998)
I Nilsson-Ehle, P Nilsson-Ehle, Liquid chromatographic assay of cerfuroxime in serum. Clinical Chemistry. ,vol. 24, pp. 365- 367 ,(1978) , 10.1093/CLINCHEM/24.2.365
Leon Aarons, Software for Population Pharmacokinetics and Pharmacodynamics Clinical Pharmacokinectics. ,vol. 36, pp. 255- 264 ,(1999) , 10.2165/00003088-199936040-00001
Antje Hoppe, Sophie Séronie-Vivien, Fabienne Thomas, Jean-Pierre Delord, Laurence Malard, Pierre Canal, Etienne Chatelut, Serum cystatin C is a better marker of topotecan clearance than serum creatinine. Clinical Cancer Research. ,vol. 11, pp. 3038- 3044 ,(2005) , 10.1158/1078-0432.CCR-04-2086
Yoshitaka Yano, Takayoshi Oguma, Hiroshi Nagata, Shimaru Sasaki, Application of Logistic Growth Model to Pharmacodynamic Analysis of in Vitro Bactericidal Kinetics Journal of Pharmaceutical Sciences. ,vol. 87, pp. 1177- 1183 ,(1998) , 10.1021/JS9801337